Ads
    Related paper
  1. QUANTITATIVE ASSESSMENT OF VASICINE AND VASICINONE IN DIFFERENT MARKETED FORMULATIONS USING HPLC
  2. Analytical Method Development and Validation Description for Quantitative Assessment of Chlorbenzuron by HPLC Procedure
  3. Herbals and its marketed formulations to treat Diabetes Mellitus (DM): An Overview
  4. DETECTION AND QUANTIFICATION OF ANTI OXIDANT MARKERS IN MARKETED HEPATOPROTECTIVE FORMULATIONS BY HPTLC TECHNIQUE
  5. SIMULTANEOUS ESTIMATION OF ATAZANAVIR SULFATE AND RITONAVIR IN MARKETED FORMULATIONS – UV SPECTROSCOPIC THREE WAVELENGTH METHOD
  6. APPLICATION OF MODEL INDEPENDENT APPROACH ON IN VITRO RELEASE OF EXTEMPORANEOUSLY PREPARED SEMISOLID FORMULATIONS CONTAINING METRONIDAZOLE WITH MARKETED SILVER SULFADIAZINE 1% CREAM, USP: A COMPARATIVE INVESTIGATION
  7. FORCED DEGRADATION STUDY OF POST-SHELF LIFE AND MARKETED TABLETS OF AMLODIPINE BY RP-HPLC
  8. A NOVEL RP ? HPLC METHOD FOR THE QUANTIFICATION OF LINAGLIPTIN IN FORMULATIONS
  9. A NOVEL RP-HPLC METHOD FOR THE QUANTIFICATION OF RUXOLITINIB IN FORMULATIONS
  10. RP-HPLC-PDA method for the simultaneous determination of Phenylepherine, Chlorpheneramine, Paracetamol and Dextromethorphan in bulk and marketed formulation